Showing results (11-20 of 98) with videos related to
Sort By:
Pageof 10
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 22, 1998
Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrineT C Chu, R R Socci, M J Ogidigben, et al.Kidney International|October 1, 1978
Statural growth of children with renal diseaseD E Potter, I GreiferThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1975
Isoproterenol- and epinephrine-induced changes in blood glucose and tissue glycogen levels in normal and diabetic rats: the influence of alteration in endogenous insulin levels and state of nourishmentD E Potter, S EllisJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1996
Ocular action of an opioid peptide, DPDPED Wang, D E PotterAnnals of the New York Academy of Sciences|July 12, 1995
Centrally mediated ocular hypotension: potential role of imidazoline receptorsW R Campbell, D E PotterThe Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocineK R Russell, D E PotterCurrent Eye Research|January 1, 1982
Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeysD E Potter, J A BurkeExperimental Eye Research|July 12, 2001
Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulationT T Moore, D E PotterEuropean Journal of Pharmacology|June 27, 1980
The effects of topical prazosin on normal and elevated intraocular pressure and blood pressure in rabbitsJ M Rowland, D E PotterJournal of Ocular Pharmacology|January 1, 1994
Potential role of imidazoline (I1) receptors in modulating aqueous humor dynamicsW R Campbell, D E PotterPageof 10